Literature DB >> 30894409

Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.

Su-Jin Shin1, Sang Yong Kim2, Yoon Young Choi3, Taeil Son3, Jae-Ho Cheong3, Woo Jin Hyung3,4, Sung Hoon Noh3, Chung-Gyu Park5,6, Hyoung-Il Kim7,3,4,5,6.   

Abstract

BACKGROUND: Microsatellite instability (MSI)-high (MSI-H) colorectal cancer is known to be associated with increased tumor-infiltrating lymphocytes (TILs), elevated host systemic immune response, and a favorable prognosis. In gastric cancer, however, MSI status has rarely been evaluated in the context of TILs and systemic immune response.
MATERIALS AND METHODS: We evaluated data for 345 patients with gastric cancer who underwent gastrectomy with MSI typing. The numbers of TILs were counted after immunohistochemical staining with anti-CD3, CD4, CD8, forkhead box P3 (Foxp3), and granzyme B to quantify the subsets of TILs. To evaluate the systemic immune response, the differential white blood cell count and prognostic nutritional index (PNI) were obtained.
RESULTS: Of the 345 patients, 57 demonstrated MSI-H tumors and 288 demonstrated non-MSI-H tumors. MSI-H tumors carried significantly higher densities of CD8+ T cells, Foxp3+ T cells, and granzyme B+ T cells and a higher ratio of Foxp3/CD4 and granzyme B/CD8. The prognostic impact of TILs differed between patients with MSI-H tumors and those with non-MSI-H tumors. The TIL subsets were not found to be significant prognostic factors for recurrence-free survival (RFS) or overall survival (OS) in the MSI-H tumor group. In the non-MSI-H tumor group, multivariate analysis showed that stage, PNI, and CD4+ T cells were independent prognostic factors for RFS, and stage, PNI, and the Foxp3/CD4 ratio were independent prognostic factors for OS.
CONCLUSIONS: The association between systemic/local immune response and prognosis differed according to MSI status. Different tumor characteristics and prognoses according to MSI status could be associated with the immunogenicity caused by microsatellite instability and subsequent host immune response. IMPLICATIONS FOR PRACTICE: This study demonstrates that the density of each subset of tumor-infiltrating lymphocytes (TILs) differed between microsatellite instability (MSI)-high and non-MSI-high tumors. Moreover, the prognostic effect of the preoperative systemic immune response status and TILs differed between the MSI-high (MSI-H) and non-MSI-H tumor groups. The present study may help to identify the mechanisms of cancer progression and develop treatment strategies for MSI-high gastric cancer. © AlphaMed Press 2019.

Entities:  

Keywords:  Gastric cancer; Microsatellite instability; Survival; Tumor‐infiltrating lymphocytes

Year:  2019        PMID: 30894409      PMCID: PMC6738289          DOI: 10.1634/theoncologist.2018-0273

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  43 in total

1.  Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery.

Authors:  Koichiro Mori; Yuji Toiyama; Susumu Saigusa; Hiroyuki Fujikawa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

2.  Decreased density of CD3+ tumor-infiltrating lymphocytes during gastric cancer progression.

Authors:  Takaaki Arigami; Yoshikazu Uenosono; Sumiya Ishigami; Daisuke Matsushita; Tetsushi Hirahara; Shigehiro Yanagita; Hiroshi Okumura; Yasuto Uchikado; Akihiro Nakajo; Yuko Kijima; Shoji Natsugoe
Journal:  J Gastroenterol Hepatol       Date:  2014       Impact factor: 4.029

Review 3.  Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

Authors:  Campbell S D Roxburgh; Donald C McMillan
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

4.  The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.

Authors:  Nicolas J Llosa; Michael Cruise; Ada Tam; Elizabeth C Wicks; Elizabeth M Hechenbleikner; Janis M Taube; Richard L Blosser; Hongni Fan; Hao Wang; Brandon S Luber; Ming Zhang; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Cynthia L Sears; Robert A Anders; Drew M Pardoll; Franck Housseau
Journal:  Cancer Discov       Date:  2014-10-30       Impact factor: 39.397

5.  High microsatellite instability predicts good prognosis in intestinal-type gastric cancers.

Authors:  Hyunki Kim; Ji Yeong An; Sung Hoon Noh; Sung Kwan Shin; Yong Chan Lee; Hoguen Kim
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

6.  Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor.

Authors:  Anna M Dahlin; Maria L Henriksson; Bethany Van Guelpen; Roger Stenling; Ake Oberg; Jörgen Rutegård; Richard Palmqvist
Journal:  Mod Pathol       Date:  2011-01-14       Impact factor: 7.842

Review 7.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

8.  Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.

Authors:  Luis F Porrata; Kay Ristow; Thomas M Habermann; Thomas E Witzig; David J Inwards; Svetomir N Markovic
Journal:  Am J Hematol       Date:  2009-02       Impact factor: 10.047

9.  Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis.

Authors:  Xiao Zheng; Xing Song; Yingjie Shao; Bin Xu; Lujun Chen; Qi Zhou; Wenwei Hu; Dachuan Zhang; Changping Wu; Min Tao; Yibei Zhu; Jingting Jiang
Journal:  Oncotarget       Date:  2017-05-22

10.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

View more
  6 in total

1.  Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy.

Authors:  Eirini Pectasides; Ioannis Chatzidakis; Vassiliki Kotoula; Georgia-Angeliki Koliou; Kyriaki Papadopoulou; Eleni Giannoulatou; Vasilios G Giannouzakos; Mattheos Bobos; Christos Papavasileiou; Sofia Chrisafi; Aikaterini Florou; Dimitrios Pectasides; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

2.  Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.

Authors:  Jie Shi; Xu Yang; Xinmei Wang; Yufeng Luo; Weixun Zhou; Hanhuan Luo; Zhaxi Bianba; Zhuoma Nima; Qian Wang; Han Wang; Ruiqian Liao; Quzhen Ciren; Mei Li; Junyi Pang
Journal:  Biomed Res Int       Date:  2022-06-13       Impact factor: 3.246

Review 3.  The immune microenvironment in gastric adenocarcinoma.

Authors:  Yana Zavros; Juanita L Merchant
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-14       Impact factor: 73.082

4.  "How Long Have I Got?" in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question.

Authors:  Huiru Guo; Hegen Li; Lihua Zhu; Jiali Feng; Xiange Huang; Jan P A Baak
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

5.  A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer.

Authors:  Shilang Xiao; Xiaoming Liu; Lingzhi Yuan; Fen Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-02

6.  Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.

Authors:  Jan Budczies; Klaus Kluck; Susanne Beck; Iordanis Ourailidis; Michael Allgäuer; Michael Menzel; Daniel Kazdal; Lukas Perkhofer; Alexander Kleger; Peter Schirmacher; Thomas Seufferlein; Albrecht Stenzinger
Journal:  J Pathol Clin Res       Date:  2022-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.